Oncology Unlocking the scalability of allogeneic CAR-T Allogeneic CAR-T, built from healthy donor T-cells, offers a different path toward scale, accessibility, and consistency.
News Jemperli label extended to include rectal cancer GSK's PD-1 inhibitor Jemperli has been cleared by the FDA as the first pre-operative cancer immunotherapy for rectal cancer.
Digital Sponsored Discover a new era of healthcare panel engagement: Grounded ... A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.
